Management of Pulmonary Hypertension in Patients on Left Ventricular Assist Device Support

Left ventricular assist devices (LVADs) are increasingly utilized for patients with end-stage heart failure (HF). Pulmonary hypertension (PH) is highly prevalent in this patient population mainly due to prolonged left (LV) and chronically elevated filling pressures. The effect of LVADs on pulmonary circulation right (RV) function has recently become an area great attention literature. PH can lead post-LVAD (RVF) that confers a high risk morbidity mortality. Multiple vasodilators, primarily used the treatment arterial (PAH), have been studied after LVAD implantation, some them shown promising results. This review aims investigate options LVADs, as well give overview about pathophysiology RVF these patients.